95% of clinical trials fail because animal testing is no substitute for human biology - Vivodyne’s robotics platform grows thousands of human tissues daily, directly tackling the biological gap behind ...
Hosted on MSN
Penn spinout that replicates human tissue for drug testing raises $40 million investment
Vivodyne, a Penn spinout that creates human tissue to replace animal testing in drug development, has raised $40 million in a second round of venture capital investment. The company, headquartered in ...
Researchers have used a novel technique to 3D print brain tissue whose cells developed into functional neurons that communicated with each other in a matter of weeks. They say the approach could be ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results